Prostatype Genomics (Sweden) Price on November 29, 2024
| PROGEN Stock | SEK 12.00 0.60 5.26% |
If you're considering investing in Prostatype Stock, it is important to understand the factors that can impact its price. As of today, the current price of Prostatype Genomics stands at 12.00, as last reported on the 11th of December 2024, with the highest price reaching 12.00 and the lowest price hitting 11.00 during the day. Prostatype Genomics maintains Sharpe Ratio (i.e., Efficiency) of -0.0326, which implies the firm had a -0.0326% return per unit of risk over the last 3 months. Prostatype Genomics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Prostatype Genomics' Variance of 59.95, risk adjusted performance of (0.0006), and Coefficient Of Variation of (7,477) to confirm the risk estimate we provide.
Prostatype Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Prostatype |
Sharpe Ratio = -0.0326
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PROGEN |
Estimated Market Risk
| 7.81 actual daily | 69 69% of assets are less volatile |
Expected Return
| -0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Prostatype Genomics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Prostatype Genomics by adding Prostatype Genomics to a well-diversified portfolio.
Prostatype Genomics Valuation on November 29, 2024
It is possible to determine the worth of Prostatype Genomics on a given historical date. On November 29, 2024 Prostatype was worth 7.7 at the beginning of the trading date compared to the closed value of 7.5. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Prostatype Genomics stock. Still, in general, we apply an absolute valuation method to find Prostatype Genomics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Prostatype Genomics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Prostatype Genomics' related companies.
| Open | High | Low | Close | Volume | |
| 7.10 | 7.90 | 7.05 | 7.65 | 90,960 | |
11/29/2024 | 7.70 | 7.70 | 7.00 | 7.50 | 55,437 |
| 7.50 | 8.30 | 6.55 | 8.05 | 18,654 |
| Backtest Prostatype Genomics | | | Prostatype Genomics History | | | Prostatype Genomics Valuation | Previous | Next |
Prostatype Genomics Trading Date Momentum on November 29, 2024
| On December 02 2024 Prostatype Genomics AB was traded for 8.05 at the closing time. The highest price during the trading period was 8.30 and the lowest recorded bid was listed for 6.55 . The volume for the day was 18.7 K. This history from December 2, 2024 contributed to the next trading day price jump. The trading delta at closing time to the next closing price was 7.33% . The trading delta at closing time to the current price is 14.00% . |
Prostatype Genomics Fundamentals Correlations and Trends
By evaluating Prostatype Genomics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Prostatype Genomics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Prostatype financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Prostatype Genomics Stock history
Prostatype Genomics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Prostatype is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Prostatype Genomics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Prostatype Genomics stock prices may prove useful in developing a viable investing in Prostatype Genomics
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. The company was founded in 2007 and is based in Solna, Sweden. Prostatype Genomics is traded on Stockholm Stock Exchange in Sweden.
Prostatype Genomics Stock Technical Analysis
Prostatype Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Prostatype Genomics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Prostatype Genomics AB cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Prostatype Genomics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Prostatype Genomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Prostatype Genomics shares will generate the highest return on investment. By undertsting and applying Prostatype Genomics stock market strength indicators, traders can identify Prostatype Genomics AB entry and exit signals to maximize returns
Prostatype Genomics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Prostatype Genomics' price direction in advance. Along with the technical and fundamental analysis of Prostatype Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Prostatype to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.0006) | |||
| Jensen Alpha | 0.0721 | |||
| Total Risk Alpha | (1.34) | |||
| Treynor Ratio | 0.07 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Prostatype Stock analysis
When running Prostatype Genomics' price analysis, check to measure Prostatype Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prostatype Genomics is operating at the current time. Most of Prostatype Genomics' value examination focuses on studying past and present price action to predict the probability of Prostatype Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prostatype Genomics' price. Additionally, you may evaluate how the addition of Prostatype Genomics to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |